Correlation Between Tarsus Pharmaceuticals and Venator Materials

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Venator Materials at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Venator Materials into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Venator Materials PLC, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Venator Materials and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Venator Materials. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Venator Materials.

Diversification Opportunities for Tarsus Pharmaceuticals and Venator Materials

0.0

Correlation Coefficient

Tarsus Pharmaceuticals  Venator Materials

Pay attention - limited upside

The 3 months correlation between Tarsus and Venator is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Venator Materials PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Venator Materials PLC and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Venator Materials. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Venator Materials PLC has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Venator Materials go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Venator Materials

If you would invest  3,188  in Tarsus Pharmaceuticals on September 15, 2024 and sell it today you would earn a total of  2,062  from holding Tarsus Pharmaceuticals or generate 64.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Venator Materials PLC

Tarsus Pharmaceuticals

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Venator Materials PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Venator Materials PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Venator Materials is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Tarsus Pharmaceuticals and Venator Materials

The main advantage of trading using opposite Tarsus Pharmaceuticals and Venator Materials positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Venator Materials can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Venator Materials will offset losses from the drop in Venator Materials' long position.

The idea behind Tarsus Pharmaceuticals and Venator Materials PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.